Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of IPG11406 tablets in adults with moderate to severe ulcerative colitis
CTR20262271Phase 2Active
- Sponsor
- Aimed Bio
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IPG11406 in autoimmune colitis, sponsored by Aimed Bio. Started Jun 2026; status: active.
02
Drugs
IPG11406
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20262271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262271.